Simultaneously, some clinical studies have shown potential usefulness of some well-known and widely recognized cardiovascular biomarkers, such as BNP, NT-proBNP, hsTnT, sST2, osteopontin, or serum uric acid, in diagnosing and prognosing the outcome of pulmonary hypertension. The gene discussed is SPP1; the disease is pulmonary arterial hypertension.